The Medical Science Liaison (MSL) is a field-based scientific expert responsible for engaging healthcare professionals, clinical experts, and key external stakeholders in support of the agreed medical strategy for an innovative therapy for Familial Chylomicronemia Syndrome (FCS), with future potential in Severe Hypertriglyceridemia (sHTG).This position can be based in München, Nürnberg, Erlangen and other cities in Germany.In this role, you will drive scientific exchange, support clinical and evidence-generation initiatives, gather actionable insights, and partner cross-functionally to ensure consistent, high-quality scientific standards. The position plays a critical part in enhancing understanding of rare lipid disorders, supporting patient pathways, and enabling informed, ethical decision-making.Executes field medical activities in accordance with Medical Excellence standards, including qualitative insights capture, engagement planning discipline, and agreed performance measures.Key ResponsibilitiesBuild meaningful scientific partnershipsAct as a trusted field-based medical and scientific expert for our product within the FCS and sHTG communities.Develop and maintain strong, long-term relationships with KOLs, healthcare professionals and academic researchers.Engage in high-quality, non-promotional scientific discussions around disease pathways, clinical evidence, patient management and emerging data, always using approved medical content.Foster balanced, scientifically rigorous dialogue and communicate relevant information clearly and effectively.Develop and maintain stakeholder engagement plans in line with Medical Excellence guidance, including stakeholder segmentation, engagement objectives, scientific exchange plans and appropriate documentation.Turn insights into impactCapture meaningful, actionable insights from interactions with HCPs, scientific meetings and other stakeholder activities.Bring the external perspective into Medical Affairs by sharing insights that can help shape:Medical strategyEvidence-generation prioritiesStakeholder engagement plansEducational initiativesKey account plans and cross-functional activitiesIdentify emerging challenges and opportunities across diagnosis, treatment access and unmet patient needs.Contribute to regular insight reviews, including monthly and quarterly discussions, helping to strengthen cross-country visibility and inform strategic decision-making.Support medical education and scientific excellenceDeliver engaging, scientifically robust education to HCPs, specialist centres and relevant networks.Partner with the Medical Advisor to develop educational content, disease-awareness initiatives and scientific resources.Provide scientific training and support to internal colleagues across functions, helping ensure accuracy, consistency and compliance.Support advisory boards, congresses and expert meetings, contributing to meaningful scientific exchange.Deliver and support education initiatives in accordance with Medical Excellence quality standards.Contribute to clinical research and evidence generationPlay an active role in evidence-generation activities, including:Phase IIIb/IV studiesInvestigator-initiated research (ISS/ISR)Non-interventional studies, registries and real-world evidence (RWE) programmesPatient identification and site feasibility discussionsEngage with investigators and research sites to support study awareness, feasibility discussions and scientific collaboration.Bring insights from clinical practice and patient care into discussions around medical and scientific strategy.Champion compliance and medical governanceEnsure all field activities and materials meet internal medical governance standards, SOPs and applicable external codes of practice.Follow Medical Excellence ways of working, including documentation standards, appropriate use of tools and agreed KPI reporting expectations.Ensure all scientific exchange is balanced, accurate, compliant and non-promotional.Understand and consistently follow medical, regulatory and pharmacovigilance processes.  
